Evaluation of proton pump inhibitor administration in hospitalized dogs in a tertiary referral hospital

被引:9
|
作者
Duxbury, Samantha [1 ,3 ]
Sorah, Emily [1 ]
Tolbert, M. Katherine [1 ,2 ]
机构
[1] North Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC USA
[2] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX 77843 USA
[3] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA
关键词
acid suppressant; canine; gastroprotectant; omeprazole; pantoprazole; MUCOSAL BLOOD-FLOW; ADVERSE EVENTS; OMEPRAZOLE; HISTAMINE; CANCER; RISK; ACHLORHYDRIA; THERAPY;
D O I
10.1111/jvim.16491
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background Although proton pump inhibitors (PPIs) are commonly administered to hospitalized dogs, prescribing patterns and appropriateness of use require continued investigation. Hypothesis/Objective Describe prescription patterns and appropriateness of use associated with PPIs in hospitalized dogs at a single tertiary care facility. We hypothesized that the majority of prescriptions would not comply with current guidelines for the rational use of acid suppressants. Animals Two hundred randomly selected hospitalized dogs. Methods Retrospective evaluation of the medical records associated with a randomly selected sample of hospitalized dogs that received PPIs between January 2013 and December 2018. Results A total of 12 610 dogs were admitted for first-time hospitalization between January 2013 and December 2018. Forty percent of these dogs (5062/12610) were prescribed a PPI PO or IV. Of the 200 randomly selected records, an adequate indication for use was identified in 27% of dogs (54/200). Of the dogs surviving to discharge, 54% (95/175) were discharged with a PPI and 51.6% (49/95) of those were prescribed an inadequate dose. Conclusions and Importance Our findings support other studies in which the majority of PPI prescriptions for hospitalized dogs at a tertiary care hospital lacked an appropriate indication. Furthermore, analysis of the prescribing patterns of dispensed PPIs identified a frequent occurrence of dosages considered inadequate, raising concern for ineffective treatment even with appropriate indications of use. With growing concern of adverse effects associated with PPI and other acid suppressant administration in human and veterinary medicine, rational use of these medications following consensus guidelines should be emphasized and treatment should be reserved for dogs with historical, physical examination, clinicopathologic, and imaging findings supportive of an appropriate indication for use.
引用
收藏
页码:1622 / 1627
页数:6
相关论文
共 50 条
  • [1] Evaluation of gastroprotectant administration in hospitalized cats in a tertiary referral hospital
    Ullal, Tarini, V
    Marks, Stanley L.
    Evenhuis, Janny, V
    Figueroa, Monica E.
    Pomerantz, Leah K.
    Forsythe, Lauren R.
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2023, 25 (10)
  • [2] Appropriateness of proton pump inhibitors use in noncritically ill hospitalized children in a tertiary hospital in Saudi Arabia
    Alosaily, Yousif A.
    Alfallaj, Jawaher M.
    Alabduljabbar, Juman S.
    Alfehaid, Elham F.
    Alfayez, Osamah M.
    Elrasheed, Mohammedelbagir
    SAUDI PHARMACEUTICAL JOURNAL, 2023, 31 (09)
  • [3] Proton pump inhibitor indications in a Brazilian tertiary hospital
    Buso Matoso, Abodia Gilda
    Mendonco Toledo Almeida, Fernanda Arantes
    Paiva, Ligia
    Margonari, Patricia Munhoz
    Bertolin, Taina Mendes
    Sousa, Alisson Alves
    Araujo de Carvalho, Ana Julia
    Cardoso Alves, Ana Vera
    dos Santos, Ebony Lima
    Teodoro, Livia Lara
    da Silva, Thiago Trajano
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (07): : 913 - 917
  • [4] Effect of the proton pump inhibitor omeprazole on the gastrointestinal bacterial microbiota of healthy dogs
    Garcia-Mazcorro, Jose F.
    Suchodolski, Jan S.
    Jones, Katherine R.
    Clark-Price, Stuart C.
    Dowd, Scot E.
    Minamoto, Yasushi
    Markel, Melissa
    Steiner, Joerg M.
    Dossin, Olivier
    FEMS MICROBIOLOGY ECOLOGY, 2012, 80 (03) : 624 - 636
  • [5] Inpatient Proton Pump Inhibitor Administration and Hospital-Acquired Clostridium difficile Infection: Evidence and Possible Mechanism
    Wombwell, Eric
    Chittum, Megan E.
    Leeser, Kayla R.
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (03): : 244 - 249
  • [6] Evaluation of Proton Pump Inhibitors Prescribing Among Hospitalized Patients: A Cross-Sectional Study
    Abukhalil, Abdallah Damin
    Ali, Ola
    Saad, Asmaa
    Falana, Hiba
    Al-Shami, Ni'meh
    Naseef, Hani A.
    Rabba, Abdullah
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 141 - 150
  • [7] Efficacy of Super High Dose Proton Pump Inhibitor Administration in Refractory Laryngopharyngeal Reflux: A Pilot Study
    Portnoy, Joel E.
    Gregory, Naomi D.
    Cerulli, Claudia E.
    Hawkshaw, Mary J.
    Lurie, Deborah
    Katz, Philip O.
    Sataloff, Robert T.
    JOURNAL OF VOICE, 2014, 28 (03) : 369 - 377
  • [8] Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more?
    Lenoir, Camille
    El Biali, Myriam
    Luthy, Christophe
    Grosgurin, Olivier
    Desmeules, Jules Alexandre
    Rollason, Victoria
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (06) : 1634 - 1641
  • [9] Effective administration method of intravenous proton pump inhibitor: A novel testing using a BRAVO catheterless pH monitoring system
    Kim, Kyu-Jong
    Park, Moo In
    Park, Seun Ja
    Cho, Sung Whan
    Moon, Won
    Kim, Gyung Mi
    Kim, Woo Mi
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2011, 22 (06): : 575 - 581
  • [10] Fatal consequence of short-term benzodiazepine administration followed by proton-pump-inhibitor therapy
    O. Peschel
    G. Roider
    G. Drasch
    W. Eisenmenger
    Forensic Science, Medicine, and Pathology, 2006, 2 (3) : 209 - 210